Abstract:Objective To investigate the relationship between the reconstitution of lymphocyte subsets after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and acute graft-versus-host disease (aGVHD),and to explore the risk factors of aGVHD.Methods The proportions of peripheral blood lymphocyte subsets of 65 patients undergoing allo-HSCT during Jan 2012 and Nov 2013 were retrospectively analyzed.The lymphocyte subsets proportion in peripheral blood lymphocyte was studied by flow cytometry on 1st,3rd,6th and 12nd month after transplantation,respectively.The risk factors of aGVHD were analyzed by Logistic regression.Results The proportion of CD3+ T subsets of the peripheral blood lymphocyte in patients who accepted allo-HSCT was decreased obviously since implantation.The proportion of CD3+ T subsets on 1st month after transplantation was decreased significantly,then gradually rose to normal [(63.65±6.64) ％] on 3rd month after transplantation.Among them,the proportion of CD3+ CD4+ T subsets was lowest on 1st month after transplantation and was reconstructed slowly to normal until 12nd month after transplantation [(23.94 ± 3.15) ％].Proportion of CD3+ CD8+ T subsets was decreased and rose to normal [(31.06±8.40)％] on 1st month after transplantation.CD3+ CD4+ and CD3+ CD8+ ratio was at a low level after transplantation,and still lower than normal at 12nd month after a slow recovery,which was approximately 0.54±0.11.The proportion of CD3+ CD25+ was low on 1st month [(2.16±0.93)％] and was increased to normal at 3rd month.Proportion of CD3-CD16+ CD56+ cells was increased significantly to (42.31±8.47) ％,and gradually fallen down to normal at 6th month.In the first 3 months after implantation,CD3+ T cells from patients with aGVHD (grade Ⅲ-Ⅳ) significantly were increased comparing with patients without aGVHD (1 month:P =0.037,3 months:P =0.045) as well as CD3+ CD25+ T cells (1 month:P =0.025,3 months:P =0.041),which was opposite to CD3+ CD4+/CD3+ CD8+ (1 month:P =0.040,3 months:P =0.043).On 1st month after transplantation,CD3+ CD4+ T cells from patients without aGVHD displayed higher than that from patients with aGVHD (grade Ⅲ-Ⅳ) (P =0.032) as well as CD3-CD16+ CD56+ cells (P =0.046),which was opposite to CD3+ CD8+ cells (P =0.029).The results of multivariate analysis showed that donor-recipient HLA mismatching (OR =2.511,P =0.024),unrelated donor (OR =2.964,P =0.018) and GVHD prophylaxis without ATG (OR =2.792,P =0.033) were the risk factors for aGVHD.Conclusion Our results support the utility of post-transplant monitoring of a peripheral blood lymphocyte subset for early warning aGVHD of patients undergoing allo-HSCT.Donorrecipient HLA mismatching,unrelated donor and GVHD prophylaxis without ATG are the risk factors for aGVHD.

[Effect of Graft Composition on Acute Graft-Versus-Host Disease in Aplastic Anemia after Haploidentical Hematopoietic Stem Cell Transplantation].

Impairment of bone marrow endothelial progenitor cells in acute graft-versus-host disease patients after allotransplant.

Relationship of Cell Compositions in Allografts with Outcomes after Haploidentical Transplantation for Acquired Severe Aplastic Anemia: Effects of CD34+ and CD14+ Cell Doses

[Analysis of Risk Factors for the Development of Acute Graft-Versus-host Disease in 151 Cases of Allo-Hematopoietic Stem Cell Transplantation].

A clinical study for acute graft-versus-host disease in patients after allogeneic hematopoietic stem cell transplantation

[Effect of Graft-Versus-host Disease on Relapse and Survival in 100 Patients after Allogeneic Hematopoietic Stem Cell Transplantation].

[Exploration of Acute Graft Versus Host Disease and Its Risk Factors after Allo-Hematopoietic Stem Cell Transplantation].

The Impact of Graft Composition on Clinical Outcomes in Pediatric Patients Undergoing Unmanipulated Hla-Mismatched/Haploidentical Hematopoietic Stem Cell Transplantation

Association Between CD34+ and CD3+ T-cells in Allogeneic Grafts and Acute Graft-Versus-host Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Study.

Clinical characteristics of acute graft-versus-host disease among different donors of allogeneic hematopoietic stem cell transplantation.

[Effect of CD8+ CD28- T Cells on Acute Graft-Versus-Host Disease after Haploidentical Hematopoietic Stem Cell Transplantation].

Risk Factors for Acute Graft-Versus-Host Disease after Allogeneic Haematopoietic Stem Cell Transplantation: A Single-Center Experience.

A Comparison of Clinical Characteristics and Prognosis of Adult Acute Graft-Versus-host Disease Between Human Leukocyte Antigen-Identical And-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation

The impact of graft composition on clinical outcomes in unmanipulated HLA-mismatched/haploidentical hematopoietic SCT

Immune reconstitution after allogeneic hematopoietic stem cell transplantation and analysis of risk factors for acute graft-versus-host disease

Study on Relationship Between the Ratio of T Cell Subtype Ⅰ and Ⅱ and the Acute Graft-Versus-host Disease

Clinical Analysis on Graft-Versus-host Disease in 55 Cases of Allogeneic Hematopoietic Stem Cell Transplantation

Risk Factors and Therapeutic Outcome of Intestinal Acute Graft Versus Host Disease in Acute Leukemia Patients after Haploidentical Peripheral Hematopoietic Stem Cell Transplantation

[Influence of Graft-Versus-host Disease on Long-Term Survival of 26 Patients with Hematologic Malignancies after Transplantation].

Effects of the Level of Chimerism and Relation Between Donor and Recipient HLA Match on Graft-Versus-host Disease after Hematopoietic Stem Cell Transplantation

Impact of Lymphocyte Subsets of Grafts on the Outcome of Haploidentical Peripheral Blood Stem Cell Transplantation